Natural Science Laboratory, Division of Medicinal and Pharmaceutical Chemistry, Department of Pharmaceutical Technology, P. O. Box 17020, Jadavpur University, Kolkata, 700032, West Bengal, India.
Department of Pharmacy, BITS-Pilani, Hyderabad Campus, Shamirpet, Hyderabad, 500078, India.
Eur J Med Chem. 2019 Mar 15;166:369-380. doi: 10.1016/j.ejmech.2019.01.077. Epub 2019 Jan 31.
Among numerous essential processes, memory and learning are important work of the brain. Epigenetic manipulations through histone acetyltransferases (HATs) and histone deacetylases (HDACs) have been implicated in memory function by modulating memory storage-related gene expression. Among these HDACs, HDAC3 is found to be important in the long-term memory process. Histone deacetylase inhibitors (HDACIs) have been established to have direct involvement to enhance the memory function through upregulation of hippocampal NR2B mRNA and phosphorylation of cyclic AMP (cAMP)-response element binding (CREB) at the NR2B gene. Though HDACIs were initially implicated as potent anticancer agents, these are also found to enhance memory or ameliorate deficits in memory dysfunction. It is done through inducing a histone hyperacetylated state. HDAC3 is a negative regulator of memory and learning and thus, deletion of HDAC3 in the dorsal hippocampus may lead to an enhanced long-term memory. Therefore, identification of potential and selective HDAC3 inhibitors may be useful in ameliorating long-term memory function and learning. In this review, detail chemico-biological and structural information of HDAC3 in memory and learning functions and benzamide-based HDAC3 inhibitors has been focussed. This may help to achieve a deep insight so that potent and selective benzamide-based HDAC3 inhibitors may be designed in future to combat memory and learning-related dysfunctions.
在众多重要过程中,记忆和学习是大脑的重要工作。组蛋白乙酰转移酶(HATs)和组蛋白去乙酰化酶(HDACs)通过调节与记忆储存相关的基因表达,参与记忆功能。在这些 HDACs 中,发现 HDAC3 对长时记忆过程很重要。组蛋白去乙酰化酶抑制剂(HDACIs)已被证实通过上调海马 NR2B mRNA 和磷酸化环磷酸腺苷(cAMP)反应元件结合(CREB)在 NR2B 基因上,直接参与增强记忆功能。尽管 HDACIs 最初被认为是有效的抗癌药物,但它们也被发现可以增强记忆或改善记忆功能障碍。这是通过诱导组蛋白超乙酰化状态来实现的。HDAC3 是记忆和学习的负调节因子,因此,在背侧海马体中删除 HDAC3 可能会导致长期记忆增强。因此,鉴定潜在的和选择性的 HDAC3 抑制剂可能有助于改善长期记忆功能和学习。在这篇综述中,重点介绍了 HDAC3 在记忆和学习功能中的化学-生物学和结构信息,以及苯甲酰胺类 HDAC3 抑制剂。这可能有助于深入了解,以便未来设计出有效的、选择性的苯甲酰胺类 HDAC3 抑制剂来对抗与记忆和学习相关的功能障碍。